The Benelux is a politico-economic union and formal international intergovernmental cooperation of three neighboring states in western Europe: Belgium, the Netherlands, and Luxembourg. The name Benelux is a portmanteau formed from joining the first two or three letters of each country's name – Belgium, Netherlands, Luxembourg – and was first used to name the customs agreement that initiated the union (signed in 1944). It is now used more generally to refer to the geographic, economic, and cultural grouping of the three countries.

Contact us

Do you want to learn more about our services and previous projects? Give us a heads up and one of our specialists will reach out to you.

Gert van Alewijk

TwinPharma Managing Partner

Purpose of the Benelux

By improving cooperation between the countries, the Benelux aims to promote the prosperity and well-being of the citizens of Belgium, the Netherlands and Luxembourg.

The Secretariat General of the Benelux is the center of this collaboration. It initiates, supports and monitors cooperation in the areas of economy, sustainability and safety.


Sales and Marketing

Entering the European market is not easy. 44 countries with different healthcare systems. What is your strategy? Apart from the Big-5, what do you do with the other 28 countries? We offer a solution for 28 countries. Sales and marketing is our core business.

Learn more


We manage, through our logistic partners with their regional warehouses, the distribution to our region (28 countries). They have the capability to handle the most demanding of specialized product order management, storage, handling and distribution requirements.

Learn more

Early Market Research

You know that market research is critical. It provides customer insights, competitive intelligence, behavioural tendencies, and product positioning. And market research increasingly is becoming an important component for linking R&D and marketing teams.

Learn more

Market Access

Achieving reimbursement and getting the right price are the 2 most important drivers for a successful launch of an innovative pharmaceuticals in our part of Europe. Health Authorities in any European country decide individually based on their local regulations, policies, framework, social values and available health care budget.

Learn more

Market Authorisation

Unlike other regions, in the EU a number of options is available to obtain a marketing authorisation. Centralised at the European Medicines Agency in Amsterdam or decentralised with the individual competent authorities of the member states, each marketing authorisation application procedure has its pros and cons. In the case of Switzerland, it has its own regulatory authority, Swissmedic, and processes.

Learn more


Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.

Learn more

How about bringing your pharmaceuticals to 200 million Europeans? We are specialized in the Nordics, the Baltics and the CEE region as well.

Experts in Benelux

We are your experts in commercialising specialized pharmaceuticals in the Benelux. What does that means? What are the hurdles and how to overcome these?

Although the Benelux seems like a strong union, the 3 countries individually have own procedures on pricing and reimbursement. We know these procedures and timelines. Please share your business case with us, and we will help you in eventually commercialising your pharmaceuticals in the Benelux. Access to KOLs in the Benelux is an issue. The workload and the demographics of physicians makes it increasingly difficult to plan meetings with KOLs. We have a strong network among KOLs in the Benelux and we always find way to communicate with the relevant KOLs.